JPS62205075A - 13-dioxinone derivative - Google Patents

13-dioxinone derivative

Info

Publication number
JPS62205075A
JPS62205075A JP4736786A JP4736786A JPS62205075A JP S62205075 A JPS62205075 A JP S62205075A JP 4736786 A JP4736786 A JP 4736786A JP 4736786 A JP4736786 A JP 4736786A JP S62205075 A JPS62205075 A JP S62205075A
Authority
JP
Japan
Prior art keywords
compound
mmot
silica gel
dioxin
hexane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP4736786A
Other languages
Japanese (ja)
Other versions
JPH0723368B2 (en
Inventor
Chikara Kaneko
金子 主税
Masayuki Sato
雅之 佐藤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Resonac Holdings Corp
Original Assignee
Showa Denko KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Showa Denko KK filed Critical Showa Denko KK
Priority to JP4736786A priority Critical patent/JPH0723368B2/en
Publication of JPS62205075A publication Critical patent/JPS62205075A/en
Publication of JPH0723368B2 publication Critical patent/JPH0723368B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Abstract

NEW MATERIAL:A 1,3-dioxin-4-one derivative of formula (X is Br, I or alkyl, alkenyl or alkynyl which may be substituted with electron attractive group; R and R' are alkyl or together form alkylene). EXAMPLE:5-Bromo-1,3-dioxin-4-one-2-spirocyclohexane. USE:Synthon, etc., useful for the synthesis of pharmaceuticals, agricultural chemicals, etc. PREPARATION:The exemplified compound can be produced e.g. by reacting 2-spirocyclohexane-1,3-dioxin-4-one with N-bromosuccinimide.

Description

【発明の詳細な説明】 (産業上の利用分野) 本発明は新規な1,3−ジオキシノン誘導体に関し、医
薬、農薬等の合成化学上のシントン等として有用な5位
が置換された1、3−ジオキシン−4−オン誘導体に関
する。
Detailed Description of the Invention (Industrial Application Field) The present invention relates to a novel 1,3-dioxinone derivative, which has 1,3-dioxynone derivatives substituted at the 5-position, which are useful as synthetic chemical synthons for pharmaceuticals, agricultural chemicals, etc. -Relating to dioxin-4-one derivatives.

(従来技術) 1.3−ジオキシン−4−オン誘導体は加熱によシ高い
反応性を有するアシルケテンを生成し、このアシルケテ
ンはインシアナート、シアナート、シアナミドまたはイ
ミンとの反応で1,3−オキサジン誘導体を、アミドと
の反応でN−アセトアセチル体を、またケテンアセター
ルと反応して4−ピロン誘導体をそれぞれ生成する。こ
れらの化合物は医薬、農薬またはその中間体等として有
用である。1,3−ジオキシン−4−オン誘導体は上記
の如くアシルケテンと同等の反応性を有し、合成化学上
程々の化合物の合成に利用できる有用なシントンとなる
が、ジケテンもまた同じような反応性を有することが知
られている。しかし、目的物の収率は一般にジケテンを
用いた場合よりもアシルケテンを用いた場合の方が優れ
ており、また、1.3−−/オキシンー4−オン化合物
としてその5位および/または6位に種々の置換基を有
する化合物を用いることにより、前記化合物に種々の置
換基の導入が可能となる。
(Prior Art) 1,3-Dioxin-4-one derivatives produce highly reactive acylketenes upon heating, and these acylketenes can be reacted with incyanates, cyanates, cyanamides or imines to form 1,3-oxazine derivatives. , reacts with amide to produce N-acetoacetyl derivatives, and reacts with ketene acetal to produce 4-pyrone derivatives. These compounds are useful as medicines, agricultural chemicals, intermediates thereof, and the like. As mentioned above, 1,3-dioxin-4-one derivatives have reactivity equivalent to that of acylketenes, and are useful synthons that can be used in the synthesis of moderate compounds in synthetic chemistry, but diketenes also have similar reactivity. It is known to have However, the yield of the target product is generally better when using an acyl ketene than when using a diketene; By using a compound having various substituents, it becomes possible to introduce various substituents into the compound.

これまでに5,6位が非置換の1,3−ジオキシン−4
−オンや逆に5,6−位に置換基のあるもの或いは6位
のみが置換されたものについてはいくつかの化合物が知
られているが(特開昭54−106478号、同59−
172485号1、同61−17580号及び同61−
22077号等)、5位置換体については5−フェニル
体が知られているのみ(特開昭59−172485号)
である。しかし、5−フェニル体はそのフェニル基を他
の基で置換することも、また、そのベンゼン核に置換基
を導入することも容易ではなく、前記の如く合成化学上
のシントンとして利用する場合、その応用範囲は自ら制
限される。
Until now, 1,3-dioxin-4 with unsubstituted 5 and 6 positions
-on, and conversely, some compounds are known that have substituents at the 5, 6-positions, or only the 6-position (JP-A-54-106478, JP-A-54-106478, JP-A-54-106478;
172485 No. 1, 61-17580 and 61-
No. 22077, etc.), and as for the 5-substituted product, only the 5-phenyl form is known (JP-A-59-172485).
It is. However, it is not easy to substitute the phenyl group with another group or introduce a substituent into the benzene nucleus of the 5-phenyl compound, and when it is used as a synthon in synthetic chemistry as described above, Its scope of application is self-limited.

このように従来5位のみが置換された1、3−ジオキシ
ン−4−オン化合物がフェニル体以外に知られていなか
ったことおよび該フェニル体が他の置換体に変換し難い
ことは、その合成法および原料化合物に依るところが大
きい。
The fact that 1,3-dioxin-4-one compounds substituted only at the 5-position have not been known in the past in any form other than the phenyl form, and that the phenyl form is difficult to convert into other substituted forms is due to the difficulty in its synthesis. Much depends on the method and raw material compound.

(発明が解決しようとする課題) 本発明者らは合成化学上のシントンとして種々の可能性
を有する応用範囲の広い5−置換1,3−ジオキシン−
4−オン誘導体を合成すべく研究の結果、本発明をなす
に至った。
(Problems to be Solved by the Invention) The present inventors have discovered that 5-substituted 1,3-dioxin- has a wide range of applications and has various possibilities as synthons in synthetic chemistry.
As a result of research aimed at synthesizing 4-one derivatives, the present invention has been completed.

(課題を解決するための手段) 本発明によれば、下記の一般式で表わされる1、3−ジ
オキシン−4−オン誘導体が提供される。
(Means for Solving the Problems) According to the present invention, a 1,3-dioxin-4-one derivative represented by the following general formula is provided.

一般式 (式中、Xは臭素、沃素または電子吸引基にて置換され
たもしくは非置換のアルキル基、アルケニル基もしくは
アルキニル基SR,R’は低級アルキル基またはRとR
1が互いに結合して一体化したアルキレン基を表わす。
General formula (wherein,
1 represents an alkylene group that is bonded to each other and integrated.

) 本発明の5位置換1,3−ジオキシン−4−オンの代表
的な化合物について、その具体的な合成法とともにいく
つか例示すれば、以下の通りである。
) Some examples of typical compounds of the 5-substituted 1,3-dioxin-4-one of the present invention are as follows, along with specific synthesis methods thereof.

(尚、以下の例に於いて化合物の前の番号は便宜上化合
物番号とする。) 2−スピサ斎キサンー1,3−ジオキシン−4−オン(
特開昭61−22077号、化合物1bと称する)50
4ダ、N−ブロモサクシイミド(NH3)641■およ
び酢酸IQmlの混合物を室温下6時間攪拌する。反応
液をジクロロメタンで希釈後十分水洗する。有機層を無
水硫酸マグネシウムで乾燥後溶媒を減圧下留去し、得ら
れる結晶をヘキサ−ジオキニンq−2−スビ%、サンを 634m9(69チ)得る。
(In the following examples, the number before the compound is used as the compound number for convenience.) 2-spisasai xan-1,3-dioxin-4-one (
JP-A No. 61-22077, referred to as compound 1b) 50
A mixture of 641 ml of N-bromosuccinimide (NH3) and IQ ml of acetic acid was stirred at room temperature for 6 hours. The reaction solution was diluted with dichloromethane and thoroughly washed with water. After drying the organic layer over anhydrous magnesium sulfate, the solvent was distilled off under reduced pressure to obtain 634 m9 (69 cm) of hexadioquinine q-2-subi% and sane.

High−resolution MS rrVz C
a1cd C,1H15Br05(M”):306−0
101 (”Br) 、308−0082(Br)−F
ound : 306 、0059(79Br)、 3
08 、0060(”Br)−IRu、、、cm  、
1760(ah)、1750.1720(CmO)−’
H−NMR(CDC23)δ:1.18−2.15(I
OH,m。
High-resolution MS rrVz C
a1cd C,1H15Br05(M”):306-0
101 (“Br), 308-0082 (Br)-F
ound: 306, 0059 (79Br), 3
08,0060(“Br)-IRu,,,cm,
1760(ah), 1750.1720(CmO)-'
H-NMR (CDC23) δ: 1.18-2.15 (I
Oh, m.

cyclohexyl)、2.18 (3H、s 、O
COMe)、4.27(IH。
cyclohexyl), 2.18 (3H, s, O
COMe), 4.27 (IH.

d e J =611ze C5−”) e 6.38
 (I Ht d * J==611z # C6−H
)−上記化合物(430111f/ 、 1.4 mm
ot)とトリエチルアミン(15611r9.1.56
mmoA)のジクロロメタン溶液(5mg)を室温下1
5分攪拌する。ジクロロメタンで希釈後水洗し、有機層
を無水硫酸マグネシウムで乾燥する。溶媒を減圧下留去
し、得られる結晶をヘキサン−エーテルより再結晶して
mp74−74.5℃のプリズムとして表記化合物(1
)を278〜(80チ)得る。
d e J =611ze C5-”) e 6.38
(I Ht d * J==611z # C6-H
) - the above compound (430111f/ , 1.4 mm
ot) and triethylamine (15611r9.1.56
A dichloromethane solution (5 mg) of mmoA) was added at room temperature.
Stir for 5 minutes. After diluting with dichloromethane and washing with water, the organic layer is dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the resulting crystals were recrystallized from hexane-ether to give the title compound (1
) to obtain 278 to (80 inches).

Ana l −Cm l e d C1put 、Br
Os : Cy 43−75 : Ht4.49 :B
r、 32.34e Found :C,43,72:
 H,4,4,O:Br 、32.43. IRu””
L3cyn−’:1735(CmO,) 。
Ana l -C m l e d C1put, Br
Os: Cy 43-75: Ht4.49: B
r, 32.34e Found:C,43,72:
H,4,4,O:Br, 32.43. IRu””
L3cyn-': 1735 (CmO,).

’H−NMR(CDCt、)δ: 1.0 ?−2,3
0(10H、m 、 eyclohexyl)。
'H-NMR (CDCt,) δ: 1.0? -2,3
0 (10H, m, eyclohexyl).

7.40(11,s 、C6−H)、 MSny’z 
: 248(”Br)(M+)。
7.40 (11,s, C6-H), MSny'z
: 248(”Br)(M+).

1 m (1,68II、 10mmot)、N−’5
i−ドサクシイミド(NIS 、 2.71 、12 
mmot)および酢酸(30m/)の混合物を室温下7
時間攪拌する。反応液をジクロロメタンで希釈後十分水
洗し、有機層を無水硫酸マグネシウムで乾燥する。溶媒
を減圧下留去し、残渣をジクロロメタン(30mAりに
溶かしてさらにトリエチルアミン(1,37,9゜13
、5 m mot)を加え、室温下20分攪拌する。反
応液を水洗後有機層を無水硫酸マグネシウムで乾燥する
。溶媒を減圧下留去し、得られる結晶をヘキサン−エー
テルより再結晶してmp97−98℃の針状晶として表
記化合物(2)を1.97.9 (67%)得る。
1 m (1,68II, 10mmot), N-'5
i-dosuccinimide (NIS, 2.71, 12
mmot) and acetic acid (30 m/) at room temperature.
Stir for an hour. The reaction solution was diluted with dichloromethane, thoroughly washed with water, and the organic layer was dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the residue was dissolved in dichloromethane (30 mA) and further diluted with triethylamine (1,37,9°13
, 5 m mot) and stirred at room temperature for 20 minutes. After washing the reaction solution with water, the organic layer is dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the resulting crystals were recrystallized from hexane-ether to obtain 1.97.9 (67%) of the title compound (2) as needle-like crystals with a mp of 97-98°C.

Anal Cal cd  CqHl、工Os : C
,36,76: He 3.7 ? −ClO2−1。
Anal Cal cd CqHl, Eng Os: C
,36,76: He 3.7? -ClO2-1.

Found : C,36,56:H,3,63,IR
&Im、!cm  。
Found: C, 36, 56: H, 3, 63, IR
&Im,! cm.

1725 (C=O) 、  ’H−NMR(CDCt
、)δ: 1.20−2.30(IOH,m、cycl
ohexyl)、7.37(IH;a、C6−H)。
1725 (C=O), 'H-NMR (CDCt
, ) δ: 1.20-2.30 (IOH, m, cycle
ohexyl), 7.37 (IH; a, C6-H).

MS m/z : 294 (M”) −2,2−ジメ
チル−1,3−ジオキシン−4−オン(前記と同じ、化
合物1aと称する)(128〜。
MS m/z: 294 (M'') -2,2-dimethyl-1,3-dioxin-4-one (same as above, referred to as compound 1a) (128~.

1 mmoL)、NBS (215m9 、1.2 m
moL)および酢酸(4mg)の混合物を室温下3時間
攪拌する。反応液をジクロロメタンで希釈後十分水洗し
、有機層を無水硫酸マグネシウムで乾燥する。溶媒を減
圧下留去し、残渣をジクロロメタン(5ml)に溶かし
てさらにトリエチルアミンC87m9,0.86mmo
t)を加え室温下15分攪拌する。反応液を水洗し、有
機層を無水硫酸マグネシウムで乾燥する。溶媒を減圧下
留去し、油状物として表記化合物(3)を74W/(3
6チ)得る。
1 mmoL), NBS (215 m9, 1.2 m
A mixture of (molL) and acetic acid (4 mg) is stirred at room temperature for 3 hours. The reaction solution was diluted with dichloromethane, thoroughly washed with water, and the organic layer was dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, the residue was dissolved in dichloromethane (5 ml), and triethylamine C87m9, 0.86 mmo
Add t) and stir at room temperature for 15 minutes. The reaction solution is washed with water, and the organic layer is dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the title compound (3) was obtained as an oil at 74 W/(3
6 h) obtain.

High−resolution  MS m/z  
Ca1cd C,H42BrO2(M+):207.0
019(Br)、209.0000(Br)、Foun
d:206.9981(Br)、208.9907(B
r)。
High-resolution MS m/z
Ca1cd C,H42BrO2(M+): 207.0
019 (Br), 209.0000 (Br), Foun
d: 206.9981 (Br), 208.9907 (B
r).

IH慴ごcm−’ : 1740 (C=O) −’ 
H−NNIR(CCl2)δ:1.73 (6H,s 
、MgX2)、7.33 (IH,s 、 C6−H)
IH value cm-': 1740 (C=O)-'
H-NNIR (CCl2) δ: 1.73 (6H,s
, MgX2), 7.33 (IH,s, C6-H)
.

1 a (1,311、10,2mmot)、NIS 
(2,76,9゜12、3 mmoL)および酢酸(2
5me)の混合物を室温下5時間攪拌する。反応液をジ
クロロメタンで希釈して十分水洗後、有機層を無水硫酸
マグネシウムで乾燥する。溶媒を減圧下留去し、残渣を
ジクロロメタン(30mlりに溶かしてさらにトリエチ
ルアミン(1,131、11mmot)を加え、室温下
20分攪拌する。反応・液を水洗後有機層を無水硫酸マ
グネシウムで乾燥する。溶媒を減圧下留去し、残渣をシ
リカゲルカラムクロマトグラフィー(シリカダル量50
g)に付する。ヘキサン−酢酸エチル(ts:t*v/
v)溶出部分より淡黄色油状物として表記化合物(4)
を1.8911(75%)得る。
1 a (1,311, 10,2 mmot), NIS
(2,76,9°12,3 mmoL) and acetic acid (2
5me) was stirred at room temperature for 5 hours. After diluting the reaction solution with dichloromethane and washing thoroughly with water, the organic layer is dried over anhydrous magnesium sulfate. The solvent was evaporated under reduced pressure, the residue was dissolved in dichloromethane (30 ml), triethylamine (1,131, 11 mmot) was further added, and the mixture was stirred at room temperature for 20 minutes. After washing the reaction solution with water, the organic layer was dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the residue was subjected to silica gel column chromatography (silica gel amount: 50
g). Hexane-ethyl acetate (ts:t*v/
v) Compound (4) described as a pale yellow oil from the eluted part
1.8911 (75%) is obtained.

High−resolution MS rrI/z 
Ca1cd C6H,IO5(M+) :253.94
38.Found :253.9448. IRνcH
c”cm−’:1735 (C=O) 、 ’H−NM
R(CC44)δ:1.72(6H,8゜MgX2)、
7.34(IH,s、C6−H)。
High-resolution MS rrI/z
Ca1cd C6H, IO5 (M+): 253.94
38. Found :253.9448. IRνcH
c"cm-': 1735 (C=O), 'H-NM
R(CC44)δ: 1.72 (6H, 8°MgX2),
7.34 (IH, s, C6-H).

5−ハロゲノ−1,3−ジオキシン−4−オン(0,5
mmot) 、モノ置換アセチレン(2,5mmot)
、Pd(Ph3P)2Ct2(0,025mmoL’)
 e Cu I (0,0−1mmot)、トリエチル
アミン(1mmoL )のDMF溶液(4m/)を封管
中室部下攪拌、あるいは60〜70℃で加熱する。反応
液をエーテルで希釈後水洗し、エーテル層を無水硫酸マ
グネシウムで乾燥する。溶媒を減圧下留去し、残渣を以
下に述べる方法で精製a)化合物(1) (124”S
’ 、 0.5 mmot)、フェニルアセチレン(2
55m9 、2.5 mmot)、Pd(Ph3P)2
Ct2(8WIIp O,01mmot)、CuI (
8m9 、0.04 mmot)、トリエチルアミン(
101m911 mmot)のDMF溶液(4mJ)を
一般操作法Aに従い70℃で12時間反応後、エーテル
抽出分画をシリカゲルカラムクロマトグラフィー(シリ
カダル量2(17)に付す。ヘキサン−酢酸エチル(2
0: 1 、 v/v )溶出部分より結晶性物質を得
、ヘキサン−エーテルより再結晶してmp 101−1
02℃の葉状晶として表記化合物(5)を51m9(3
8%)得る。なお原料も42〜(34チ)回収する。
5-halogeno-1,3-dioxin-4-one (0,5
mmot), monosubstituted acetylene (2,5mmot)
, Pd(Ph3P)2Ct2(0,025mmoL')
e A DMF solution (4 m/) of Cu I (0.0-1 mmot) and triethylamine (1 mmol) is stirred in a sealed tube or heated at 60 to 70°C. The reaction solution was diluted with ether, washed with water, and the ether layer was dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the residue was purified by the method described below.a) Compound (1) (124"S
', 0.5 mmot), phenylacetylene (2
55m9, 2.5 mmot), Pd(Ph3P)2
Ct2 (8WIIp O, 01 mmot), CuI (
8m9, 0.04 mmot), triethylamine (
After reacting a DMF solution (4 mJ) of 101m911 mmot) at 70°C for 12 hours according to general procedure A, the ether extracted fraction was subjected to silica gel column chromatography (silica dul amount 2 (17). Hexane-ethyl acetate (2
0:1, v/v) A crystalline substance was obtained from the eluted portion and recrystallized from hexane-ether to obtain mp 101-1.
51 m9 (3
8%). In addition, 42 to (34 inches) of raw materials are also recovered.

Anal Ca1cd C1,H1603: C、76
,10: H,6,01。
Anal Calcd C1, H1603: C, 76
, 10: H, 6, 01.

Found :C@75.95 : H,5,80* 
IRucHcL3m−’:1740(C=O) 、  
H−NMR(CDCl2)δ: 1.10−2.33 
(10H。
Found: C@75.95: H, 5, 80*
IRucHcL3m-': 1740 (C=O),
H-NMR (CDCl2) δ: 1.10-2.33
(10H.

m、 cyclohexyl) 、 7.20−7.7
0(6H,m、ArH,C6−H)。
m, cyclohexyl), 7.20-7.7
0(6H, m, ArH, C6-H).

MS m/z : 268 (M+)。MS m/z: 268 (M+).

b)化合物(2)(147”9t 0.5mmoA)、
フェニルアセチレン(2551nl/e 2.5 yy
smoA) 、Pd(Ph3P)2ct2(18m9 
、 0.025mmot)、CuI(811F/、  
0.04mmat )、トリエチルアミン(10111
IfI、 1 mmot)のDMF溶液(4IIAりを
一般操作法人に従い室温下30分反応させ、a)と同様
に後処理し表記化合物化合物(2) (1,058g 
、 3.6 mmoL )、トリメチルシリルアセチレ
ン(1,761、18mmoA)、pci(ph3p)
2cz2(126”!/ p O,18mmot)、C
uI(58m9m 0.29mmot)、トリエチルア
ミン(727”/ # 7.2 mmoL )のDMF
溶液(281M’)を一般操作法人に従い室温下40分
反応させ、エーテル抽出 二分画をシリカダルカラムク
ロマトグラフィー(シリカゲル量589)に付す。ヘキ
サン−酢酸エチル(20: 1 、 v/v )溶出部
分より結晶性物質を得、ペンタyよシ再結晶してmp7
3−74℃の針状晶として表記化合物(6)を873■
(92L)得る。
b) Compound (2) (147"9t 0.5mmoA),
Phenylacetylene (2551nl/e 2.5yy
smoA), Pd(Ph3P)2ct2(18m9
, 0.025 mmot), CuI (811F/,
0.04mmat), triethylamine (10111
IfI, 1 mmot) in DMF solution (4IIA) was reacted at room temperature for 30 minutes according to the general operating corporation, and post-treated in the same manner as a) to obtain the title compound (2) (1,058 g
, 3.6 mmoL), trimethylsilylacetylene (1,761, 18 mmoA), pci (ph3p)
2cz2 (126”!/p O, 18mmot), C
uI (58m9m 0.29mmot), triethylamine (727”/ #7.2 mmoL) in DMF
The solution (281M') was reacted at room temperature for 40 minutes according to the general operating corporation, extracted with ether, and the two fractions were subjected to silica dull column chromatography (silica gel amount: 589). A crystalline substance was obtained from the hexane-ethyl acetate (20:1, v/v) eluate, and recrystallized from pentane to obtain mp7.
873■ of the title compound (6) as needle-like crystals at 3-74℃
(92L) obtained.

Anal Ca1cd  C,4H2,)03Si: 
Ct 63.60 : He 7.62 。
Anal Calcd C,4H2,)03Si:
Ct 63.60: He 7.62.

cttct3  ml・ Found : C,63,30:H,7,89e I
Ry、、、  cm  。
cttct3 ml・Found: C, 63, 30: H, 7, 89e I
Ry, cm.

2160(C==C)、1740(C=0)、’H−N
MR(CCl2)δ:0.22(9H,a 、MgX2
)、1.30−2.30(IOH,m。
2160 (C==C), 1740 (C=0), 'H-N
MR (CCl2) δ: 0.22 (9H,a, MgX2
), 1.30-2.30 (IOH, m.

cyclohsxyl) e 7.37 (IH* s
 、 C6−H)*MS m/z :264(M )。
cyclohsxyl) e 7.37 (IH*s
, C6-H)*MS m/z: 264 (M).

化合、物(4) (127■、 0.5 mmoA)、
1−ヘキシン(205”9 s 2.5 mmot)、
Pd(Ph3P)2Ct□(18m9e0.025mm
ot)、CuI(8m9.0.0 4 mmot)、 
トリエチルアミン(101”!/ 61 mmot)の
DMF溶液(5ml )を一般操作法人に従い室温下1
.5時間反応させ、エーテル抽出分画をシリカダルカラ
ムクロマトグラフィー(シリカゲル量129)に付す。
Compound, substance (4) (127■, 0.5 mmoA),
1-hexyne (205”9 s 2.5 mmot),
Pd(Ph3P)2Ct□(18m9e0.025mm
ot), CuI (8m9.0.04 mmot),
A DMF solution (5 ml) of triethylamine (101”!/61 mmot) was added at room temperature for 1 hour according to the general operating company.
.. The reaction was allowed to proceed for 5 hours, and the ether extracted fraction was subjected to silica column chromatography (silica gel amount: 129).

ヘキサン−酢酸エチル(20:1)溶出部分より淡黄色
油状物として表記化合物(7)を76〜(73%)得る
From the fraction eluted with hexane-ethyl acetate (20:1), 76-(73%) of the title compound (7) was obtained as a pale yellow oil.

High−resolution MS rrv/z 
Ca1cd C,2H,60,(M”) :208.1
100. Found : 208.1122. IR
y””cIn−’:1730 (C=O) 、 ’H−
NMR(CC14)δ:0.73−1.67(7Hs 
m * Me(CH2)2cu2c==c) p 1.
72 (6He s tMeX2) t2.00−2.
83 (2H、m 、 Me(CH2)2CH2C=C
) 、 7.27(I Hv s e C6−)I )
 。
High-resolution MS rrv/z
Ca1cd C,2H,60,(M”) :208.1
100. Found: 208.1122. IR
y""cIn-': 1730 (C=O), 'H-
NMR (CC14) δ: 0.73-1.67 (7Hs
m*Me(CH2)2cu2c==c) p1.
72 (6He s tMeX2) t2.00-2.
83 (2H, m, Me(CH2)2CH2C=C
), 7.27 (I Hv se C6-) I)
.

8)  2.2−ツメチル−5−トリメチルシリルエチ
ニル−1,3−ジオキシン−4−オン 化合物(4)(127t%F、 0.5mmot ) 
)リメチルシリルアセチレン(24511g、 2.5
mmot) 。
8) 2.2-methyl-5-trimethylsilylethynyl-1,3-dioxin-4-one compound (4) (127t%F, 0.5mmot)
) Limethylsilylacetylene (24511g, 2.5
mmot).

Pd(Ph3P)2CL2 (18j’li’ 、 0
.025mmoL ) 、 Cul(8m? 、 0.
04mmoL ) 、 )リエチルアミン(101#。
Pd(Ph3P)2CL2 (18j'li', 0
.. 025mmoL), Cul(8m?, 0.025mmoL), Cul(8m?, 0.
04mmol), ) ethylamine (101#.

1mmot)のDMF溶液(5ml)を一般操作法Aに
従い室温下35分、反応させ、エーテル抽出分画をシリ
カゲルカラムクロマトグラフィー(シリカゲルi6g)
に付す。ヘキサン−酢酸エチル(25: 1 、 V/
V )溶出部分より黄褐色油状物として表記化合物(8
)を99IQ(88チ)得る。
A DMF solution (5 ml) of 1 mmot) was reacted for 35 minutes at room temperature according to general procedure A, and the ether extracted fraction was subjected to silica gel column chromatography (silica gel i6 g).
Attach to. Hexane-ethyl acetate (25:1, V/
V) The title compound (8
) gets 99IQ (88chi).

Hlgh−resolution MS m/z Ca
1cd C1,H460,Si(M+):224.08
67、Found:224.0864.IRy:”、’
、、’c@−’ :2160(CミC) 、 l 74
0 (C=0) 、 ’H−NMR(CCl2)δ:0
.21(9HtssMe5Si)el、75(6H,l
、MgX2)、7.33(I H# a * C6−H
) − 化合物(4) (127m? 、 0.5mmot) 
、グロノ4ルギルアルコール(140〜m 2.5mm
ol ) 。
Hlgh-resolution MS m/z Ca
1cd C1, H460, Si (M+): 224.08
67, Found: 224.0864. IRy:”,'
,,'c@-' :2160(CmiC), l 74
0 (C=0), 'H-NMR (CCl2) δ: 0
.. 21(9HtssMe5Si)el, 75(6H,l
, MgX2), 7.33 (I H#a*C6-H
) - Compound (4) (127m?, 0.5mmot)
, Grono 4 Rugyl Alcohol (140~m 2.5mm
ol).

Pd(Ph3P)2Ct2(18mg、 0.025m
mot) 、 CuI (8m9 p O,04mmo
t) 、 )リエチルアミン(10lay。
Pd(Ph3P)2Ct2 (18mg, 0.025m
mot), CuI (8m9pO,04mmo
t), ) ethylamine (10lay.

1mmot)のDMF溶液(5r117りを一般操作法
AK従い60℃で50分反応させ、エーテル抽出分画を
シリカゲルカラムクロマトグラフィー(シリカゲルil
o、F)に付す。ヘキサン−酢酸エチル(2: l 、
 v/v )溶出部分より淡黄色油状物として表記化合
物(9)を43η(47%)得る。
A DMF solution (1 mmot) was reacted at 60°C for 50 minutes according to the general procedure AK, and the ether extracted fraction was subjected to silica gel column chromatography (silica gel il
o, F). Hexane-ethyl acetate (2: l,
v/v) From the eluted portion, 43η (47%) of the title compound (9) was obtained as a pale yellow oil.

High−resolution MS mHz Ca
1cd C,Hl、)04(M+) :182.058
0 、Found :182.0590 、 IR,C
HC4c、−1:3600 (HCCa)、3450(
OH)、1735(C=0)。
High-resolution MS mHz Ca
1cd C, Hl, )04(M+) :182.058
0, Found:182.0590, IR,C
HC4c, -1:3600 (HCCa), 3450 (
OH), 1735 (C=0).

’ H−NMR(coct3)δ:1.75(6H,a
、MgX2)、3.08(IH,bra 、OH) 、
 4.45 (2H,brs 、 CH,、OH)、 
7.40(I He a e C,s−H) −〔化合
物(2) 、 (4) )とモノ置換オレフィンとの5
−ヨード体化合物(2)および(4) (0,5m m
at )とモノ置換オレフィン(1m mat ) 、
 Pd(OAc)2(0,05m mot) 、 Na
HCO3(1,25m mol )テトラブチルアンモ
ニウムクロライド(NBu4Ct) 、 0.5m m
otのDMF溶液(7ml)をアルゴン気流中60−7
0’Cで反応させる。反応液をエーテルで希釈して水洗
後エーテル層を無水硫酸マグネシウムで乾燥する。溶媒
を減圧下留去し、残渣を以下に述べる方法で精製する。
' H-NMR (coct3) δ: 1.75 (6H, a
, MgX2), 3.08 (IH, bra, OH),
4.45 (2H,brs,CH,,OH),
7.40(IHeaeC,s-H)-[5 of compound (2), (4)) and monosubstituted olefin
-Iodo compound (2) and (4) (0,5m m
at ) and monosubstituted olefin (1m mat ),
Pd(OAc)2(0.05m mot), Na
HCO3 (1,25 mmol) tetrabutylammonium chloride (NBu4Ct), 0.5 mmol
A DMF solution (7 ml) of
React at 0'C. The reaction solution was diluted with ether, washed with water, and the ether layer was dried over anhydrous magnesium sulfate. The solvent is distilled off under reduced pressure, and the residue is purified by the method described below.

化合物(2) (147111fi、 0.5mmot
) 、アクリル酸エチル(100W、 1mmot) 
、 Pd(OAc)2(1119゜0.05mmot)
、NaHCO,(1059,1,25mmot) 。
Compound (2) (147111fi, 0.5mmot
), ethyl acrylate (100W, 1mmot)
, Pd(OAc)2 (1119°0.05mmot)
, NaHCO, (1059,1,25mmot).

NBu4C2(139119、0,5m mot)を一
般操作法Bに従い1h反応させ、 エーテル抽出分画を
シリカゲルカラムクロマトグラフィー(シリカゲル!−
5g)ニ付す。ヘキサン−酢酸エチル(10: 1 、
 v/v )溶出部分より結晶性物質を得、ヘキサンよ
り再結晶してmp 67℃の鱗片状晶として表記化合物
(10を90〜(67チ)得る。
NBu4C2 (139119, 0.5 m mot) was reacted for 1 h according to general procedure B, and the ether extracted fraction was subjected to silica gel column chromatography (silica gel!-
5g) Attach d. Hexane-ethyl acetate (10:1,
v/v) A crystalline substance was obtained from the eluted portion, and recrystallized from hexane to obtain the title compound (90 to (67) of 10) as scaly crystals with a mp of 67°C.

Anal、 Ca1cd C,4HB305: C,6
3、15;H,6,81−(3H、t * J =7H
z 、OCH2Mり 、1.13−2.27 (10H
−m。
Anal, Ca1cd C,4HB305: C,6
3,15;H,6,81-(3H,t*J=7H
z, OCH2Mri, 1.13-2.27 (10H
-m.

(IH,s、C6−H)、MS mHz : 168 
(M+−C3H60)。
(IH, s, C6-H), MS mHz: 168
(M+-C3H60).

−オン 化合物(4)(254W9,1mmot)、アクリル酸
エチル(200m9 、2mmot ) 、 Pd(O
Ac)2(22J19.0.1mmoL ) 、 Na
HCO3(2101119m 2.5mmoL)、NB
u4C1(2781rr9.1mmot)のDMF溶液
(12m/)を一般操作法Bに従い1.5h’反応させ
、エーテル抽出分画をシリカゲルカラムクロマトグラフ
ィー(シリカゲルts9)に付す。ヘキサン−酢酸エチ
ル(7:1 、 v/v )溶出部分より結晶性物質を
得、ヘキサンより再結晶してmp 64−65℃のグリ
ズムとして表記化合物α力を151■(67% )得る
-one compound (4) (254W9, 1mmot), ethyl acrylate (200m9, 2mmot), Pd(O
Ac)2(22J19.0.1mmol), Na
HCO3 (2101119m 2.5mmoL), NB
A DMF solution (12 m/) of u4C1 (2781rr9.1 mmot) was reacted for 1.5 h' according to general procedure B, and the ether extracted fraction was subjected to silica gel column chromatography (silica gel ts9). A crystalline material was obtained from the fraction eluted with hexane-ethyl acetate (7:1, v/v), and recrystallized from hexane to obtain 151 μm (67%) of the title compound as a grism with a mp of 64-65°C.

Anal、Ca1cd C,、H1405: C、58
,40;H,6,24。
Anal, Calcd C,, H1405: C, 58
, 40; H, 6, 24.

Found : C+ 58−48 ; H* 6−3
6− IRI’ cH” cm−’ : 1735 #
1700(C=O)、’H−聞飢coct、 )δ: 
1.28 (3H,t 。
Found: C+ 58-48; H* 6-3
6-IRI'cH"cm-': 1735 #
1700 (C=O), 'H-coct, )δ:
1.28 (3H,t.

6.60 J =7 Hz 、 OCR2M@) 、    (2
H,ABq、J=16Hz 、 CH=7.07   
              □CHCO) 、 7.
32(LH,s 、 C6−H) 、 MS mHz 
:226(M+) 。
6.60 J = 7 Hz, OCR2M@), (2
H, ABq, J=16Hz, CH=7.07
□CHCO), 7.
32 (LH,s, C6-H), MS mHz
:226(M+).

12) @ −2,2−ジメチル−5−(3−フタルイ
ミド−1−ブロイニル) −1,3−ジオキシン−4−
オン化合物(4)(254!19 、1 mmot)、
N−7リル7タルイミド(3741119、2mmot
)、Pd (OA c )2(22”9+ 0.1 m
mot) 、NaHCO3(210’? + 2.5゜
mmot) 、NBu CL (2781119t 1
 mmot)のDMF溶液(12#111?)を一般操
作法Bに従い5.sh反応させ、エーテル抽出分画をシ
リカゲルカラムクロマトグラフィー(シリカゲル量io
g)に付す。
12) @-2,2-dimethyl-5-(3-phthalimido-1-broynyl)-1,3-dioxin-4-
compound (4) (254!19, 1 mmot),
N-7lyl 7-talimide (3741119, 2mmot
), Pd (OA c )2(22”9+0.1 m
mot), NaHCO3 (210'? + 2.5゜mmot), NBu CL (2781119t 1
5. DMF solution (12#111?) of Mmot) according to general procedure B. sh reaction, and the ether extracted fraction was subjected to silica gel column chromatography (silica gel amount io
g).

ヘキサン−酢酸エチル(5: 1 、 v/v )溶出
部分よシ結品性物質を得、ヘキサン−ジクロロメタンよ
シ再結晶してmp 148−149℃の鱗片状晶として
雫記化合物(2)を5011Ig(16%)得る。
A crystalline substance was obtained from the hexane-ethyl acetate (5:1, v/v) eluate, and recrystallized from hexane-dichloromethane to give the compound (2) as scaly crystals with a mp of 148-149°C. 5011Ig (16%) was obtained.

Anal、Ca1cd C,7H,5No5: C、6
5,17:H,4,83:N、4.47. Found
 :C,65,36:H,5,13:N、4.41゜I
RycH”3ays″″’ : 1770,1735(
sh)、1710(C=O)。
Anal, Calcd C,7H,5No5: C,6
5,17:H, 4,83:N, 4.47. Found
:C, 65, 36:H, 5, 13:N, 4.41゜I
RycH"3ays""': 1770, 1735 (
sh), 1710 (C=O).

ax ’H−NMR(CDC2,)δ: 1.68 (6H、
s 、MgX2) 。
ax 'H-NMR (CDC2,) δ: 1.68 (6H,
s, MgX2).

4、35 (2H、d 、J =5 Hz −NCR2
CH=CH) −6,08(I H、d 、J =16
 Hz 、NCR2CH=CH) 、6.50 (I 
H。
4, 35 (2H, d, J = 5 Hz - NCR2
CH=CH) -6,08 (I H, d, J = 16
Hz, NCR2CH=CH), 6.50 (I
H.

d t 、J =5.16 Hz 、NCR2CH=C
H) −7,17(I H。
d t , J =5.16 Hz, NCR2CH=C
H) -7,17 (I H.

s、C6−H)、7.57−8.07(4H,m、Ar
H)、MSrrv’z : 255 (M+−03H6
0) −化合物(4)(127mg+ 0.5 mmo
L ) 、アクロレインジエチルアセタール(130m
9+ 1mmot)+Pd(OAe)2 (1119、
0,05mmot)、NaHCOs(10511!9.
1.25mmot)、NBuaCt(139”9 。
s, C6-H), 7.57-8.07 (4H, m, Ar
H), MSrrv'z: 255 (M+-03H6
0) - Compound (4) (127 mg + 0.5 mmo
L), acrolein diethyl acetal (130m
9+ 1mmot)+Pd(OAe)2 (1119,
0.05 mmot), NaHCOs (10511!9.
1.25 mmot), NBuaCt (139”9.

0、5 mmot)のDMF溶液(6x/)を一般操作
法Bに従い4.sh反応させ、エーテル抽出分画をシリ
カゲルカラムクロマトグラフィー(シリカゲル量6JF
)K付−t。ヘキサン−ff[工fkc3:1゜v/v
 )溶出部分よシ黄褐色油状物として表記化合物(至)
を31!(24ts)得る。
4.0.5 mmot) in DMF solution (6x/) according to general procedure B. sh reaction, and the ether extracted fraction was subjected to silica gel column chromatography (silica gel amount: 6JF).
) with K-t. Hexane-ff[fkc3:1゜v/v
) The compound described as a yellowish brown oil in the eluted area (to)
31! (24ts) obtained.

IRν:フ513儒−’: 1725(C=0)、’H
−間紅■ユ、)δ: 1.23 (6H、t 、J=7
Hz 、(OCR2Me)X2 ) 。
IRν: Fu513 Confucian-': 1725 (C=0),'H
-Mako ■Yu, ) δ: 1.23 (6H, t, J=7
Hz, (OCR2Me)X2).

1.70 (6H、s r Me X 2 ) + 2
.50 (3H、s + MeC=C) t4.12(
4H、q 、 J=7Hz、 (OCR2Me)X2)
 、 7.00(l H、s 、 C6−H)、MSm
/z : 256(M+)。
1.70 (6H, s r Me X 2 ) + 2
.. 50 (3H, s + MeC=C) t4.12(
4H, q, J=7Hz, (OCR2Me)X2)
, 7.00 (l H, s, C6-H), MSm
/z: 256 (M+).

14)  2.2−&メチルー5−エトキシカルがニル
エチル−化合物αO(24m9 、0.106 mmo
A )の酢酸エチル溶液(4IILl)にPd−C(6
ダ)を加え、水素気流中、接触還元に付す。水素の吸収
が止んだ後(30分)、Pd−Cを炉去する。溶媒を減
圧下留去し、残渣をシリカゲルカラムクロマトグラフィ
ー(シリカゲル!2.5g)に付す。ヘキサン−酢酸エ
チル(5: 1 、 V/V )溶出部分よシ油状物と
して表記化合物α→を18m9(74チ)得る。
14) 2.2-&methyl-5-ethoxylic is nylethyl-compound αO (24m9, 0.106 mmo
Pd-C (6
) and subjected to catalytic reduction in a hydrogen stream. After hydrogen absorption has stopped (30 minutes), Pd-C is removed from the furnace. The solvent was distilled off under reduced pressure, and the residue was subjected to silica gel column chromatography (silica gel! 2.5 g). The fraction eluted with hexane-ethyl acetate (5:1, V/V) gave 18 m9 (74 m) of the title compound α→ as an oily substance.

High−resolution MS mHz Ca
l cd C11H1605(M+) :CHCj3 
 −1  。
High-resolution MS mHz Ca
l cd C11H1605 (M+) :CHCj3
-1.

228.0998.Found: 228.0999.
lR11,、!cm  。
228.0998. Found: 228.0999.
lR11,,! cm.

1720.1715 (sh) (C=O) −’H−
NMR(CCl2)δ:1、23 (3H、t 、J 
=7 Hz 、0CR2Me ) 、1.63 (6H
1720.1715 (sh) (C=O) -'H-
NMR (CCl2) δ: 1, 23 (3H, t, J
=7 Hz, 0CR2Me), 1.63 (6H
.

s 1Me X 2 ) 、2.43 (4H、s 、
CH2CH2C0) 、4.06(2H,q 、 J=
7Hz 、OCR2Me)、 6.93(IH,s 。
s 1Me X 2 ) , 2.43 (4H, s ,
CH2CH2C0) , 4.06 (2H,q, J=
7Hz, OCR2Me), 6.93 (IH,s.

a)化合物(6) (10611#9 、0.4 mm
ot)のテトラヒドロフラン溶液(3mAりにI M 
NB u a Fテトラヒドロフラン溶液(0,4x/
)を寒剤冷却下かきまぜながら加え、直ちにエーテルを
加えて水洗する。エーテル層を無水硫酸マグネシウムで
乾燥後溶媒を減圧下留去し、残渣をシリカゲルカラムク
ロマトグラフィー(シリカゲル量4.5g)に付す。ヘ
キサン−酢酸エチル(7: 1 、 v/v )溶出部
分より結晶性物質を得、ヘキサンよシ再結晶してmp 
87−87.5℃の針状晶として表記化合物α啼を33
mg(43チ)得る。
a) Compound (6) (10611#9, 0.4 mm
ot) in tetrahydrofuran solution (IM at 3 mA)
NB u a F tetrahydrofuran solution (0.4x/
) while stirring while cooling with refrigerant, immediately add ether and wash with water. After drying the ether layer over anhydrous magnesium sulfate, the solvent was distilled off under reduced pressure, and the residue was subjected to silica gel column chromatography (silica gel amount: 4.5 g). A crystalline substance was obtained from the hexane-ethyl acetate (7:1, v/v) eluate and recrystallized from hexane to give mp
33 of the indicated compound α as needle crystals at 87-87.5°C.
mg (43 g) is obtained.

Anal、 Ca1cd C11H1203: C、6
8,74:H、6,29。
Anal, Ca1cd C11H1203: C, 6
8,74:H, 6,29.

Found : C、68,80a、 H、6,04、
IRI/cH”3cIn−’ :3300(C=CH’
) 、 1735 (C= 0 ’) 、 ’E−NM
R(CDCl2)δ:1.12−2.28(IOH,m
、cyelohexyl ) 、3.10(IH,s、
C=CH) 、7.53 (I H、s 、Cb−H)
 −MS mHz : 192 (M+) 。
Found: C, 68,80a, H, 6,04,
IRI/cH"3cIn-': 3300 (C=CH'
), 1735 (C=0'), 'E-NM
R(CDCl2)δ: 1.12-2.28 (IOH, m
, cyelohexyl), 3.10 (IH,s,
C=CH), 7.53 (IH,s,Cb-H)
-MS mHz: 192 (M+).

b)化合物(6) (106In9.0.4 mmot
)のDMF溶液(4Ill  )  K  FK・ 2
H2QC38mg 、  0.4  mmot)  の
 DMF (1,51nAり−H20(0,5m )溶
液を氷水冷却下かきまぜながら加え、直ちにエーテルを
加えて水洗する。エーテル層を無水硫酸マグネシウムで
乾燥後溶媒を減圧下留去し、得られる納品をヘキサンよ
り再結晶して表記化合物(ト)を68mノ(89%)得
る。
b) Compound (6) (106In9.0.4 mmot
) DMF solution (4Ill) KFK・2
A solution of H2QC (38 mg, 0.4 mmot) in DMF (1,51 nA-H20 (0.5 m)) was added while stirring under ice-water cooling, and immediately ether was added and washed with water. After drying the ether layer over anhydrous magnesium sulfate, the solvent was removed under reduced pressure. After evaporation, the resulting product was recrystallized from hexane to obtain 68 m (89%) of the title compound (g).

16)  2.2−ジメチル−5−エチニル−1,3−
ジオキシン−4−オン化合物(8) (85m9 、0
.38 mmoL )のDMF溶液(3a/)に、FK
・2H20(36M9 、0.38 mmot)のDM
F (2rnl ) −H2O(1rrtl )溶液を
氷水冷却下かきまぜながら加え、直ちにエーテルを加え
て水洗する。エーテル層を無水硫酸マグネシウムで乾燥
後溶媒を減圧下留去し、残渣をシリカゲルカラムクロマ
トグラフィー(シリカゲル量4g)に付す。
16) 2,2-dimethyl-5-ethynyl-1,3-
Dioxin-4-one compound (8) (85m9, 0
.. FK was added to a DMF solution (3a/) of 38 mmol
・DM of 2H20 (36M9, 0.38 mmot)
A F (2rnl)-H2O(1rrtl) solution is added while stirring under cooling with ice water, and immediately ether is added and washed with water. After drying the ether layer over anhydrous magnesium sulfate, the solvent was distilled off under reduced pressure, and the residue was subjected to silica gel column chromatography (silica gel amount: 4 g).

ヘキサン−酢酸エチル(7: 1 、 v/v )溶出
部分よりmp54〜55℃の表記化合物QQを44II
1g(76%)得る。
From the hexane-ethyl acetate (7:1, v/v) eluted portion, the indicated compound QQ at mp 54-55°C was extracted with 44II.
1 g (76%) obtained.

High −resolution MS rrV′z
 Ca1ed C6HBO3(M”) :152.04
72. Found: 152.0452.IRνcH
c′3c*−’:3300(C=CH)、1740(C
=O)、’H−NMR(CCl2)δ:1.72 (6
H,s 、MeX2)、2.98 (IH,s 、C=
CH) 。
High-resolution MS rrV'z
Caled C6HBO3 (M”): 152.04
72. Found: 152.0452. IRνcH
c'3c*-': 3300 (C=CH), 1740 (C
=O), 'H-NMR (CCl2) δ: 1.72 (6
H,s, MeX2), 2.98 (IH,s, C=
CH).

ユ、、!″、父ヤケ。Yu...! ”, my father is burnt.

化合物(至)(192ffiり+ 1 mmot)の酢
酸エチル溶液(7at ) ニPd−C(201ff9
)を加え、水素気流中、接触還元に付す。水素の吸収が
止んだ後(15分)、Pd−Ct−ip去する。溶媒を
減圧下留去し、残渣をシリカゲルカラムクロマトグラフ
ィー(シリカゲル量10g)に付す。ヘキサン−酢酸エ
チル(20:1 + v/v )溶出部分よシ結晶性物
質を得、4ンタンよシ再結晶してmp 34−35℃の
針状晶として表記化合物(ロ)を169m9(86%)
得る。
Compound (to) (192ffi + 1 mmot) in ethyl acetate solution (7at) Pd-C (201ff9
) and subjected to catalytic reduction in a hydrogen stream. After hydrogen absorption has stopped (15 minutes), Pd-Ct-ip is removed. The solvent was distilled off under reduced pressure, and the residue was subjected to silica gel column chromatography (silica gel amount: 10 g). A crystalline substance was obtained from the hexane-ethyl acetate (20:1 + v/v) eluted portion, which was recrystallized from 4 tons to give the title compound (b) as needle-shaped crystals with a temperature of 169 m9 (86 m9). %)
obtain.

Anal、Ca1cd C,、H1603: C、67
,32:It 8.22−Found : C、67,
17:Hr 8.17. IRI/””3m−’ :1
720(C=O) 、 ’H−NMR(CCl2)δ:
1.07(3H,t、J=7Hz 、CH2Me)、1
.33−2.43(IOH,m。
Anal, Calcd C,, H1603: C, 67
, 32: It 8.22-Found: C, 67,
17:Hr 8.17. IRI/""3m-': 1
720 (C=O), 'H-NMR (CCl2) δ:
1.07 (3H, t, J=7Hz, CH2Me), 1
.. 33-2.43 (IOH, m.

6yclohexyl) 、 2.16 (2H+dq
 r J=1 、7Hz 。
6yclohexyl), 2.16 (2H+dq
rJ=1, 7Hz.

CH2Me ) 、 6.79 (IH,t 、 J=
IHz 、C6−H)、MSm/z : 196 CM
”) − 化合物Q*(201+り、 1.37 mmoL )の
酢酸エチル溶液(7a/)にpa−c (21mq>を
加え、水素気流中、接触還元に付す。水素の吸収が止ん
だ後(20分)、Pd−Cを炉去する。溶媒を減圧下留
去し、得られる残渣をシリカゲルカラムクロマトグラフ
ィー(シリカダル量6g)に付す。ヘキサン−酢酸エチ
ル(5: 1 、 v/v )溶出部分よシ油状物とし
て表記化合物α枠を1797119(84%)得る。
CH2Me), 6.79 (IH,t, J=
IHz, C6-H), MSm/z: 196 CM
") - Add pac-c (21 mq> to an ethyl acetate solution (7a/) of compound Q* (201+, 1.37 mmol) and subject it to catalytic reduction in a hydrogen stream. After hydrogen absorption has stopped ( 20 minutes), Pd-C is removed in the oven. The solvent is distilled off under reduced pressure, and the resulting residue is subjected to silica gel column chromatography (silica gel amount: 6 g). Elution with hexane-ethyl acetate (5: 1, v/v). 1797119 (84%) of the title compound alpha frame is obtained as a partially distilled oil.

High resolution MS rn/z C
a1cd C3I1120!、(Fl’l+) :15
6.0785 、 Found : 156.0783
.IR1/cH”3m−’ :1720 (C=0 )
、 ’H−NMR(CCl2)δ:1.1°0 (3)
t。
High resolution MS rn/z C
a1cd C3I1120! , (Fl'l+) :15
6.0785, Found: 156.0783
.. IR1/cH"3m-': 1720 (C=0)
, 'H-NMR (CCl2) δ: 1.1°0 (3)
t.

t l J=7H19CH2Me ) 11.63 (
6H1B 、MeX2) 12.18(2H,q、J=
7H2,CH2Me)、6.78(IH。
t l J=7H19CH2Me ) 11.63 (
6H1B, MeX2) 12.18 (2H, q, J=
7H2, CH2Me), 6.78 (IH.

化合物(2)(118mり、 0.4 mmot)とア
リルトリメチルシラン(686m9.6mmot)の無
水アセトニトリルB液(50ml )をパイレックスフ
ィルターを用いて100W高圧水銀燈で5時間光照射(
〉300 nm )する。溶媒を減圧下留去し、残渣を
シリカゲルカラムクロマトグラフィー(シリカ’y’ル
P410 g)に付す。ヘキサン−酢酸エチル(1s 
: 1. v/v )溶出部分よシ油状物として表記化
合物α呻を43mり(52%)得る。
Compound (2) (118 m, 0.4 mmot) and allyltrimethylsilane (686 m, 9.6 mmot) in anhydrous acetonitrile solution B (50 ml) were irradiated with a 100 W high-pressure mercury lamp for 5 hours using a Pyrex filter.
>300 nm). The solvent was distilled off under reduced pressure, and the residue was subjected to silica gel column chromatography (silica gel P410 g). Hexane-ethyl acetate (1s
: 1. v/v) 43 m (52%) of the title compound α was obtained as an oily substance from the eluted portion.

High −resolution MS mHz C
a1cd Cl2H1603(M+) :208.11
00. Found : 208.1103.IRνc
Hc”m−’:1720(C=O)、’H→皿(CDC
t、)δ:1.20−2.30(10H+m、cycl
ohexyl ) + 2.97 (2H+ddd +
J=1.4 、2.8 、6H2,CH2=CHCH2
−)、4.89−5.40(2H,m、cH2=cnc
H2−)、s、51(xn、adt 、J=6.9 、
16Hz、CH2=CHCH2−)、6.87(IH,
t。
High-resolution MS mHz C
a1cd Cl2H1603 (M+): 208.11
00. Found: 208.1103. IRνc
Hc"m-': 1720 (C=O), 'H→dish (CDC
t,) δ: 1.20-2.30 (10H+m, cycle
ohexyl ) + 2.97 (2H+ddd +
J=1.4, 2.8, 6H2, CH2=CHCH2
-), 4.89-5.40 (2H, m, cH2=cnc
H2-), s, 51 (xn, adt, J=6.9,
16Hz, CH2=CHCH2-), 6.87 (IH,
t.

J=1.4 Hz + 06−H) 。J = 1.4 Hz + 06-H).

カリウムtart−ブトキシド(2,24,5’ 、 
20mmot)のツメチルホルムアミド溶液(40ff
il)に寒剤冷却下かき混ぜなからtert−ブチルホ
ルミルアセテート(2,889、20mmot)を徐々
に加える。この溶液にヨードメタン(3−109+ 2
2mmot)を一度に加え、この温度で2時間さらに室
温で10分攪拌する。水を加え10 % HClで弱酸
性としエーテルで抽出する。有機層を無水硫酸マグネシ
ウムで乾燥し溶媒を減圧下留去する。残渣をエーテルに
溶かし冷たい2.5チ水酸化ナトリウム水溶液(IQ#
+J)で3回抽出し、アルカリ層をエーテルで洗う。1
0 % HClで酸性としエーテル抽出して飽和食塩水
で洗う。有機層を無水硫酸マグネシウムで乾燥後溶媒を
減圧下留去し、残渣をシリカゲルカラムクロマトグラフ
ィー(シリカゲル量30g)に付す。ヘキサン−酢酸エ
チル(20:1 、v/v)溶出部分より油状物として
tert−ブチル12−メチルホルミルアセテートを4
85In9(15qlJ)得る。
Potassium tart-butoxide (2,24,5',
20mmot) in trimethylformamide solution (40ff
tert-butylformyl acetate (2,889, 20 mmot) was gradually added to the mixture under cooling with cryogen and stirring. Add iodomethane (3-109+2
2 mmot) was added at once and stirred at this temperature for 2 hours and then at room temperature for 10 minutes. Add water, make weakly acidic with 10% HCl, and extract with ether. The organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. Dissolve the residue in ether and add cold 2.5% aqueous sodium hydroxide solution (IQ#
+J) three times and wash the alkaline layer with ether. 1
Acidify with 0% HCl, extract with ether, and wash with saturated saline. After drying the organic layer over anhydrous magnesium sulfate, the solvent was distilled off under reduced pressure, and the residue was subjected to silica gel column chromatography (silica gel amount: 30 g). Tert-butyl 12-methylformyl acetate was extracted as an oil from the hexane-ethyl acetate (20:1, v/v) eluate.
85In9 (15qlJ) is obtained.

11tνcH””cm−’  :1715.1690(
C=O) 。
11tνcH""cm-': 1715.1690(
C=O).

’ H−NMRCCC14)δ: 1.23 (3HX
215.d、J=7Hz。
' H-NMRCC14) δ: 1.23 (3HX
215. d, J = 7Hz.

MeCHCO2) 、 1.52 (9H、s 、 O
tert−Bu)、1.63(3HX315. s 、
MeC=CHOH) 、 3.22 (I HX215
.dqtJ = 2.7 Hz 、 MeCHCO2)
 、6.92(IHX315.d、J=12 Hz 、
 MaC=CHOH) 、 9.68 (I HX 2
15.d、J=2Hz 。
MeCHCO2), 1.52 (9H, s, O
tert-Bu), 1.63 (3HX315.s,
MeC=CHOH), 3.22 (I HX215
.. dqtJ = 2.7 Hz, MeCHCO2)
, 6.92 (IHX315.d, J=12 Hz,
MaC=CHOH), 9.68 (I HX 2
15. d, J=2Hz.

HCO)、11.35(IHX315 、d 、J=1
2Hz。
HCO), 11.35 (IHX315, d, J=1
2Hz.

MeC= CHOH) 。MeC=CHOH).

Sem1 carbazone : mp 126−1
28℃(エーテル−ヘキサン)Anal、Ca1cd 
C7H17N504 : C、50,22:H、7,9
6:N、、19.52.Found  :C,50,2
4:H,8,16:N。
Sem1 carbazone: mp 126-1
28℃ (ether-hexane) Anal, Calcd
C7H17N504: C, 50,22:H, 7,9
6:N,, 19.52. Found: C, 50, 2
4:H, 8,16:N.

19.51゜ 上記化合物C316mC516m9r2に寒剤冷却下無
水i酸(612m)、 6 mmoL )ついでアセト
ン(232mp 、 4 mmot)を加え、攪拌しつ
つ濃硫酸(196ff9.2mmot)を徐々に加える
。5分間攪拌後、氷水中で30分さらに室温で30分攪
拌する。炭酸水素ナトリウム水溶液に注ぎ無水酢酸臭が
消失するまで攪拌する。反応液をエーテルで抽出し、エ
ーテル層を無水硫酸マグネシウムで乾燥する。溶媒を減
圧下留去し、残渣をシリカゲルカラムクロマトグラフィ
ー(シリカゲル量9g)に付す。ヘキサン−酢酸エチル
(5: 1 、 v/v )溶出部分よシ、油状物とし
て表記化合物(イ)を5.0mり(18%)得る。
19.51° To the above compound C316mC516m9r2, add acid anhydride (612m, 6 mmol) and then acetone (232mp, 4 mmot) under cooling with cryogen, and gradually add concentrated sulfuric acid (196ff, 9.2 mmot) while stirring. After stirring for 5 minutes, stir in ice water for 30 minutes and further at room temperature for 30 minutes. Pour into aqueous sodium hydrogen carbonate solution and stir until the acetic anhydride odor disappears. The reaction solution was extracted with ether, and the ether layer was dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the residue was subjected to silica gel column chromatography (9 g of silica gel). From the fraction eluted with hexane-ethyl acetate (5:1, v/v), 5.0 ml (18%) of the title compound (a) was obtained as an oil.

High−resolution MS m/z Ca
1cd C,H1005(M”) :142.0628
.Found:142.0627.IRJ/    c
m   。
High-resolution MS m/z Ca
1cd C, H1005 (M”): 142.0628
.. Found:142.0627. IRJ/c
m.

1720 (C=O) 、 ’H−NMR(CDC/1
.、)δ:1.6B(6H。
1720 (C=O), 'H-NMR (CDC/1
.. , ) δ: 1.6B (6H.

s 、MeX2)、1.76、(3H,s 、C5−M
e’)、6.87(IH。
s, MeX2), 1.76, (3H,s, C5-M
e'), 6.87 (IH.

s 、C6−H) 。s, C6-H).

これらの合成例からも明らかな如く、5位モノ置換の1
.3−ジオキシン−4−オン類は6位モノ置換および5
.6位ジ置換の1.3−ジオキシン−4−オン類と同様
な濃硫酸の共存下にβ−ケト酸のtert−ブチルエス
テルをアセトン中無水酢酸で処理する方法によって得ら
れる化合物もあるが(例えば、化合物20)、この方法
は収率が良くないため、通常は5,6位が非置換の1.
3−ジオキシ−4−オン類を出発物質として先ずその5
位臭素化物又は沃素化物を得、これを更にパラジウム化
合物を触媒とするクロスカップリング反応にかけ、ハロ
ゲンの置換部位へ選択的に炭素置換基を導入する方法が
行われる。閘、アセチレン類とのクロスカップリング反
応については、山中ら(Chem、 Pharm。
As is clear from these synthetic examples, the 5-position monosubstituted 1
.. 3-dioxin-4-ones are monosubstituted at the 6-position and
.. There is also a compound obtained by treating tert-butyl ester of β-keto acid with acetic anhydride in acetone in the presence of concentrated sulfuric acid similar to the 6-position disubstituted 1,3-dioxin-4-ones ( For example, for compound 20), since this method does not have a good yield, it is usually used for compound 1.
First, using 3-dioxy-4-ones as a starting material,
A method is used in which a brominated or iodized product is obtained, which is further subjected to a cross-coupling reaction using a palladium compound as a catalyst, to selectively introduce a carbon substituent into the halogen substitution site. Regarding cross-coupling reactions with acetylenes, Yamanaka et al. (Chem, Pharm.

Bull、、26.3843(1978) 、5ynt
hesis、312(1983))、Ca5sar ら
 [J、Organomet、Chem−+93.25
3(1975)]、Hackら〔同259)、荻原ら(
Tetra hedron 1*tt、+ 4467 
(1975) rSynthesis 777 、 (
1977) )等の報告があり、また、オレフィン量と
の反応についてはHeckら(J、Org、Chem、
、 37 、2320(197−2) ) 、山中ら[
Chem、 Pharm、Bull、、30 、364
7 (1982) 、同27.193(1979))、
”!efferyら(J、Chem、Soc、*Che
m、Commun、、1287(1984))等の報告
があるが、ジオキシノン環は一般に熱に対して不安定で
あるため比較的低い温度でも速みゃかに反応が進行する
ような方法を工夫することが望ましい。
Bull, 26.3843 (1978), 5ynt
hesis, 312 (1983)), Ca5sar et al. [J, Organomet, Chem-+93.25
3 (1975)], Hack et al. [ibid. 259), Ogiwara et al.
Tetra hedron 1*tt, +4467
(1975) rSynthesis 777, (
1977) ), and regarding the reaction with the amount of olefin, Heck et al.
, 37, 2320 (197-2)), Yamanaka et al. [
Chem, Pharm, Bull, 30, 364
7 (1982), 27.193 (1979)),
”!effery et al. (J, Chem, Soc, *Che
Although there are reports such as ``M, Commun, 1287 (1984),'' dioxinone rings are generally unstable to heat, so it is necessary to devise a method that allows the reaction to proceed rapidly even at relatively low temperatures. This is desirable.

また、更に化合物19の合成で示したように光反応を利
用する方法もある。
Furthermore, as shown in the synthesis of Compound 19, there is also a method that utilizes a photoreaction.

かくて得られた5位置換1.3−ジオキシン−4−オン
類は前述の如く、他の公知の1.3−ジオキシン−4−
オン類と同様に、各種合成化学上のシントンとして利用
される。
The 5-substituted 1,3-dioxin-4-ones thus obtained are, as described above, other known 1,3-dioxin-4-ones.
Like ons, it is used as a synthon in various synthetic chemistry.

邸黒人  鮎#I電工孫戎ゐ釉 べil!、(舟弯1@鴫煽−House Negro Ayu #I electrician grandson ゐglaze Beil! , (Funaki 1 @ Shizuki-

Claims (1)

【特許請求の範囲】 一般式 ▲数式、化学式、表等があります▼ (式中、Xは臭素、沃素または電子吸引基にて置換され
たもしくは非置換のアルキル基、アルケニル基もしくは
アルキニル基;R、R′は低級アルキル基またはRとR
′が互いに結合して一体化したアルキレン基を表わす。 )で表わされる1,3−ジオキシン−4−オン誘導体。
[Claims] General formula ▲ Numerical formula, chemical formula, table, etc. ▼ (In the formula, , R' is a lower alkyl group or R and R
′ represents an alkylene group that is bonded to each other and integrated. ) A 1,3-dioxin-4-one derivative represented by
JP4736786A 1986-03-06 1986-03-06 1,3-dioxynone derivative Expired - Lifetime JPH0723368B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP4736786A JPH0723368B2 (en) 1986-03-06 1986-03-06 1,3-dioxynone derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4736786A JPH0723368B2 (en) 1986-03-06 1986-03-06 1,3-dioxynone derivative

Publications (2)

Publication Number Publication Date
JPS62205075A true JPS62205075A (en) 1987-09-09
JPH0723368B2 JPH0723368B2 (en) 1995-03-15

Family

ID=12773139

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4736786A Expired - Lifetime JPH0723368B2 (en) 1986-03-06 1986-03-06 1,3-dioxynone derivative

Country Status (1)

Country Link
JP (1) JPH0723368B2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007091705A (en) * 2005-09-05 2007-04-12 Adeka Corp Compound having dioxinone structure, optical filter and optical recording material comprising the compound
US20140295347A1 (en) * 2013-03-30 2014-10-02 Rohm And Haas Electronic Materials, Llc Acid generators and photoresists comprising same

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007091705A (en) * 2005-09-05 2007-04-12 Adeka Corp Compound having dioxinone structure, optical filter and optical recording material comprising the compound
US20140295347A1 (en) * 2013-03-30 2014-10-02 Rohm And Haas Electronic Materials, Llc Acid generators and photoresists comprising same
US9256125B2 (en) * 2013-03-30 2016-02-09 Rohm And Haas Electronic Materials, Llc Acid generators and photoresists comprising same

Also Published As

Publication number Publication date
JPH0723368B2 (en) 1995-03-15

Similar Documents

Publication Publication Date Title
Donnelly et al. The chemistry of 2'-amino analogs of 2'-hydroxychalcone and its derivatives
JPS6393777A (en) Chemoluminescent 1, 2-dioxetane compound, its production and light emitting method
SU715026A3 (en) Method of preparing furocoumarins
Schultz et al. A new 2-azatricyclo [4.4. 0.02, 8] decenone synthesis and ketene formation by retro-Diels-Alder reaction
DE1958600C3 (en) 3-substituted 6-O3-dimethylisoxazol-4-yO-methyl-3a-alkyl U, 3a, 43,9,9a, 9b-octahydro-3H-benz [e] indene-7 (8H) -ones and their Manufacturing
Katada et al. Thermal cycloaddition reactions of thiocarbonyl compounds. Part 3. A novel [4+ 2] cycloaddition reaction of thiocarbonyl compounds with o-quinone methanides
JPS62205075A (en) 13-dioxinone derivative
Fodor et al. New reaction of L-ascorbic acid: unusual molecular complexes of the product
Attwood et al. A convenient procedure for the deoxygenation and homologation of D-ribose derivatives
Prein et al. Diastereoselective Synthesis of 4‐Hydroperoxy‐3, 5‐cyclohexadienones in the Photooxygenation of Hydroxyethyl‐Substituted Phenols
Barco et al. Enantioselective formal synthesis of (−)-ovalicin using quinic acid as a chiral template
JPH0585550B2 (en)
Fitzgerald et al. Ring expansion of 2-benzylidenecoumaran-3-ones—a synthesis of flavones
US3227722A (en) Process for the preparation of pyredine
Chaumont-Olive et al. Total synthesis of spiromastilactone A
RU2722595C1 (en) Method of producing 4-formyl-6,7-dihydroxy-benzo[b]thiophene-3-carboxylic acid ester
IE48824B1 (en) Aurone derivatives
EP0494771B1 (en) Process for producing optically active dihydropyran derivatives
JPH04247065A (en) Process for producing isoprenoidcyclopropane 1,1-dicarboxylate and its derivative
Ahluwalia et al. Synthesis of Linear Pyranocoumarins: Xanthoxyletin, 4-Methyl-xanthyletin, and 4-Phenylxanthyletin
Chang et al. One-pot synthesis of benzofused 8-oxabicyclo [3.3. 1] nonanes via GaCl 3-mediated cyclocondensation of o-allylbenzaldehydes and 1, 3-dicarbonyl synthons
JPS61118380A (en) Novel 1,4-benzodioxane and 1,4-benzodioxine derivative and preparation thereof
JPS5916878A (en) Production of 2,4-dihydroxy-3-acetylquinoline
JP2023548916A (en) Method for producing biliverdin or its derivatives
JPH0324047A (en) Production of phenylmalonic acid monoanilide derivative and 3-phenyl-2-quinolone derivative